Global In Vitro Toxicology Testing Market - Forecast to 2021

Jun 3, 2016 - Markets and Markets - 260 pages - USD $5,650
Report Summary Table of Contents Request Details Related
Global In Vitro Toxicology Testing Market by Product, Type (ADME), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (Genomics, Transcriptomics), Method (Cellular Assays), Industry (Pharmaceutical) - Forecast to 2021

The global in vitro toxicology testing market is expected to USD 27.36 billion by 2021 from USD 14.15 billion in 2016, at a CAGR of 14.1% between 2016 and 2021. By product, the market includes assays, reagents & labware, and services. Based on toxicity endpoints & tests, the market is segmented into systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, skin sensitization & irritation, genotoxicity, neurotoxicity, and organ toxicity. The systemic toxicity segment will hold the largest share of the in vitro toxicology testing toxicity endpoints & tests market in 2016.

The geographic segments included in this report are Europe, North America, Asia, and Rest of the World (RoW). Europe is expected to account for the largest share in the global the in vitro toxicology testing market in 2016. Asia is expected to register the fastest growth in the forecast period.

The growth of this market is mainly driven by opposition to animal testing, new & promising technologies, increasing R&D to detect toxicity at early stages and insufficient databases to facilitate the use of in vitro test methods. In addition, growing demand for in vitro toxicology in the European market and increasing drug discovery and innovation, & modernization in the in vitro toxicity testing market provides a growing opportunity to this market.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global in vitro toxicology testing market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders such as Agilent Technologies, Inc. (U.S.), Covance, Inc. (A subsidiary of LabCorp) (U.S.), Bio-Rad Laboratories, Inc. (U.S.), General Electric Company (U.S.), Eurofins Scientific SE (Luxembourg), BioReliance, Inc. (A subsidiary of Merck & Co, Inc.) (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.).


Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:
  • Product Development/Innovation: Product portfolios of the top players in the in vitro toxicology testing market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market
  • Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the in vitro toxicology testing market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various in vitro toxicology testing across geographies
  • Market Diversification: Exhaustive information about new products, recent developments, and investments in the in vitro toxicology testing market

Order Today!
FORMAT: Single User PDF - Delivered by Email $5,650 USD
LICENSE: Single User
DELIVERY: By Email - 1 Business Day


The Fast Market Research Advantage
Only the Best
All of our research is sourced from the most trusted and established global analysts and consultancies

Client Focused
From start-ups to multinationals, we focus on providing the right research to our diverse client base

Shop Securely
Our US-based customer service team and eCommerce systems adhere to the highest data security standards

Industry-leading Customer Support
Individualized assistance from our expert staff is never more than an email or phone call away


BEST PRICE GUARANTEE
We are committed to providing the best research at the lowest cost. We will match any published price for the same report, guaranteed!

EASY ORDERING
Once you’ve found the right report, click ‘order now’ and complete the checkout process using any major credit card, check or wire/bank transfer.

Need multi-user or enterprise license pricing? Contact us for a custom quote!
MC, Visa, AMEX, Diners, Discovery, JCB

About the Publisher
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. The company publishes high-level strategically analyzed reports for over ten industry verticals and serves as a business intelligence partner to Fortune 500 companies across the world.